Semaglutide Market – Global Outlook and Forecast 2022-2028

Semaglutide (trade names Rybelsus, Ozempic) is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer, kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient. An injection version was approved in 2017 in the United States, and in Europe, Canada, and Japan in 2018. An version which is taken by mouth was approved in 2019 in the United States. It is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected. It was developed by the Danish company Novo Nordisk.

This report contains market size and forecasts of Semaglutide in global, including the following market information:

Global Semaglutide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Download FREE Sample of this Report @ https://www.enrmarketresearch.com/download-free-sample/7209448/global-semaglutide-2022-2028-328

Global Semaglutide Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Semaglutide companies in 2021 (%)

The global Semaglutide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Semaglutide include Novo Nordisk. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Semaglutide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Semaglutide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Semaglutide Market Segment Percentages, by Type, 2021 (%)

Injection

Oral

Global Semaglutide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Semaglutide Market Segment Percentages, by Application, 2021 (%)

Hospital

Clinic

Global Semaglutide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Semaglutide Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Semaglutide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Semaglutide revenues share in global market, 2021 (%)

Key companies Semaglutide sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Semaglutide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novo Nordisk

Table of content

1 Introduction to Research & Analysis Reports
1.1 Semaglutide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semaglutide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semaglutide Overall Market Size
2.1 Global Semaglutide Market Size: 2021 VS 2028
2.2 Global Semaglutide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Semaglutide Sales: 2017-2028
3 Company Landscape
3.1 Top Semaglutide Players in Global Market
3.2 Top Global Semaglutide Companies Ranked by Revenue
3.3 Global Semaglutide Revenue by Companies
3.4 Global Semaglutide Sales by Companies
3.5 Global Semaglutide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Semaglutide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Semaglutide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Semaglutide Players in Global Market
3.8.1 List of Global Tier 1 Semaglutide Companies
3.8.2 List of Global Tier 2 and Tier 3 Semaglutide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Semaglutide Market Size Markets, 2021 & 2028
4.1.2 Injection
4.1.3 Oral
4.2 By Type – Global Semaglutide Revenue & For

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.enrmarketresearch.com/
Similar Reports: Global Semaglutide Market Insights and Forecast to 2028

Global Semaglutide Market Research Report 2021